©The Author(s) 2016.
World J Nephrol. Nov 6, 2016; 5(6): 489-496
Published online Nov 6, 2016. doi: 10.5527/wjn.v5.i6.489
Published online Nov 6, 2016. doi: 10.5527/wjn.v5.i6.489
Table 3 Antibiotic dosing for patients who are undergoing hemodialysis[31]
| Empirical dosing pending culture results |
| Vancomycin plus empirical gram-negative rod coverage based on local antibiogram data |
| Or |
| Vancomycin plus gentamicin (Cefazolin may be used in place of vancomycin in units with a low prevalence of methicillin-resistant staphylococci) |
| Vancomycin: 20 mg/kg loading dose infused during the last hour of the dialysis session, and then 500 mg during the last 30 min of each subsequent dialysis session |
| Gentamicin (or tobramycin): 1 mg/kg, not to exceed 100 mg after each dialysis session |
| Ceftazidime: 1 g iv after each dialysis session |
| Cefazolin: 20 mg/kg iv after each dialysis session |
| For Candida infection |
| An echinocandin (caspofungin 70 mg iv loading dose followed by 50 mg iv daily; intravenous micafungin 100 mg iv daily; or anidulafungin 200 mg iv loading dose, followed by 100 mg iv daily); fluconazole (200 mg orally daily); or amphotericin-B |
- Citation: Suzuki M, Satoh N, Nakamura M, Horita S, Seki G, Moriya K. Bacteremia in hemodialysis patients. World J Nephrol 2016; 5(6): 489-496
- URL: https://www.wjgnet.com/2220-6124/full/v5/i6/489.htm
- DOI: https://dx.doi.org/10.5527/wjn.v5.i6.489